Financial Instruments (Notes)

3 Months Ended

Mar. 31, 2022

Investments, Debt and Equity Securities [Abstract]

Financial Instruments

Financial Instruments

Restricted Cash and Cash Equivalents

The Company had restricted cash and cash equivalents of $29 and $33 at March 31, 2022 and December 31, 2021, respectively. The Company's restricted cash and cash equivalents are primarily related to balances that are restricted for payment of distributions to certain of the Company's current and former employees. In addition, the Company's restricted cash and cash equivalents include RS Cogen's cash that is restricted under its senior credit facility. Restricted cash and cash equivalents are reflected primarily in other assets, net in the consolidated balance sheets.